Well, Penny, I'm committed to holding the INSV I've got, but at least I've made some money on BNVI, DARA, DSCO RODM (should have never sold the shares I bought at $1.00 in July--now $5+)
Rainmaker has some good ideas on this one.
I don't see how or really why, INSV would keep going for very long as an independent company.
Big-name partners of B & L and PFE. A bit smaller partner name of Inspire. I'm thinking one of these guys will buy INSV out really soon. I think potential partners see small biotech companies getting bid way up with any FDA announcement. They're seeing cheap prices they might acquire these smaller bios go by the wayside.
I think INSV will be snatched up $1.25-$1.50 before year-end.
News 
Market Data 
Discover 
